- All sections
- C - Chemistry; metallurgy
- C12N - Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media
- C12N 5/0783 - T cells; NK cells; Progenitors of T or NK cells
Patent holdings for IPC class C12N 5/0783
Total number of patents in this class: 9406
10-year publication summary
257
|
443
|
591
|
773
|
1008
|
1127
|
1171
|
1307
|
1137
|
344
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Immatics Biotechnologies GmbH | 1144 |
675 |
Iovance Biotherapeutics, Inc. | 301 |
211 |
The Trustees of the University of Pennsylvania | 4122 |
170 |
The Regents of the University of California | 18943 |
163 |
The United States of America, as represented by the Secretary, Department of Health and Human Services | 2737 |
145 |
Cellectis | 397 |
121 |
Board of Regents, The University of Texas System | 5370 |
103 |
Juno Therapeutics, Inc. | 365 |
100 |
Baylor College of Medicine | 875 |
91 |
Novartis AG | 11238 |
89 |
Memorial Sloan-Kettering Cancer Center | 1789 |
89 |
Autolus Limited | 232 |
80 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
75 |
Regents of the University of Minnesota | 2620 |
72 |
City of Hope | 943 |
68 |
H. Lee Moffitt Cancer Center and Research Institute, Inc. | 829 |
65 |
Kite Pharma, Inc. | 315 |
57 |
FATE Therapeutics, Inc. | 176 |
56 |
The Johns Hopkins University | 5377 |
55 |
Kyoto University | 2732 |
54 |
Other owners | 6867 |